Filing Details
- Accession Number:
- 0001179110-16-028199
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-03 16:08:19
- Reporting Period:
- 2016-08-01
- Filing Date:
- 2016-08-03
- Accepted Time:
- 2016-08-03 16:08:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1166776 | Paul Thomas | 22 Cherry Hill Dr Danvers MA 01923 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.01 Par Value | Acquisiton | 2016-08-01 | 10,000 | $18.94 | 31,311 | No | 4 | M | Direct | |
Common Stock, $.01 Par Value | Disposition | 2016-08-01 | 10,000 | $118.65 | 21,311 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (right to buy) | Disposition | 2016-08-01 | 10,000 | $0.00 | 10,000 | $18.94 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-01-29 | 2020-05-26 | No | 4 | M | Direct |
Footnotes
- Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exerciseable as following: 50% on the date shown in Table II, Column 6, and 50% on January 29, 2015.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $118.5000 and $118.9100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.